PQ 190
190. Deputy Shay Brennan asked the Minister for Health if her Department has assessed the potential national cost savings associated with weight based dosing of pembrolizumab (keytruda), in light of the Cork University Hospital study indicating a saving of €635,417.50 for 28 patients over two years. [28352/26]
Introduced
21 April 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2026
Summary
190. Deputy Shay Brennan asked the Minister for Health if her Department has assessed the potential national cost savings associated with weight based dosing of pembrolizumab (keytruda), in light of the Cork University Hospital study indicating a saving of €635,417.50 for 28 patients over two years. [28352/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 21 April 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-04-21/190/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-04-21/pq_190